397 related articles for article (PubMed ID: 18567864)
1. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.
Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A
Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864
[TBL] [Abstract][Full Text] [Related]
2. Thymoma and paraneoplastic myasthenia gravis.
Marx A; Willcox N; Leite MI; Chuang WY; Schalke B; Nix W; Ströbel P
Autoimmunity; 2010 Aug; 43(5-6):413-27. PubMed ID: 20380583
[TBL] [Abstract][Full Text] [Related]
3. Infrequent and low AIRE expression in thymoma: difference in AIRE expression among WHO subtypes does not correlate with association of MG.
Suzuki E; Kobayashi Y; Yano M; Fujii Y
Autoimmunity; 2008 Aug; 41(5):377-82. PubMed ID: 18568643
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the genetic pathogenesis of myasthenia gravis caused by CTLA-4 gene polymorphism].
Mao HT; Wang XB; Zhang L; Gu HT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):574-8. PubMed ID: 15583985
[TBL] [Abstract][Full Text] [Related]
5. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
[TBL] [Abstract][Full Text] [Related]
6. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
[TBL] [Abstract][Full Text] [Related]
7. A CTLA4high genotype is associated with myasthenia gravis in thymoma patients.
Chuang WY; Ströbel P; Gold R; Nix W; Schalke B; Kiefer R; Opitz A; Klinker E; Müller-Hermelink HK; Marx A
Ann Neurol; 2005 Oct; 58(4):644-8. PubMed ID: 16178018
[TBL] [Abstract][Full Text] [Related]
8. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
9. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S
Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
[TBL] [Abstract][Full Text] [Related]
11. Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex.
Savino W; Manganella G; Verley JM; Wolff A; Berrih S; Levasseur P; Binet JP; Dardenne M; Bach JF
J Clin Invest; 1985 Sep; 76(3):1140-6. PubMed ID: 2413072
[TBL] [Abstract][Full Text] [Related]
12. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
[TBL] [Abstract][Full Text] [Related]
14. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes.
Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A
Front Immunol; 2020; 11():664. PubMed ID: 32373124
[TBL] [Abstract][Full Text] [Related]
15. A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.
Nagvekar N; Moody AM; Moss P; Roxanis I; Curnow J; Beeson D; Pantic N; Newsom-Davis J; Vincent A; Willcox N
J Clin Invest; 1998 May; 101(10):2268-77. PubMed ID: 9593783
[TBL] [Abstract][Full Text] [Related]
16. Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma.
Luther C; Poeschel S; Varga M; Melms A; Tolosa E
J Neuroimmunol; 2005 Jul; 164(1-2):124-8. PubMed ID: 15923045
[TBL] [Abstract][Full Text] [Related]
17. Genomic organization and lack of transcription of the nicotinic acetylcholine receptor subunit genes in myasthenia gravis-associated thymoma.
Geuder KI; Marx A; Witzemann V; Schalke B; Kirchner T; Müller-Hermelink HK
Lab Invest; 1992 Apr; 66(4):452-8. PubMed ID: 1583885
[TBL] [Abstract][Full Text] [Related]
18. Thymoma-associated myasthenia gravis: On the search for a pathogen signature.
Cufi P; Soussan P; Truffault F; Fetouchi R; Robinet M; Fadel E; Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():29-35. PubMed ID: 24440286
[TBL] [Abstract][Full Text] [Related]
19. Pathological aspects of malignant and benign thymic disorders.
Müller-Hermelink HK; Marx A
Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune regulator expression in thymomas with or without autoimmune disease.
Liu Y; Zhang H; Zhang P; Meng F; Chen Y; Wang Y; Yao Y; Qi B
Immunol Lett; 2014 Sep; 161(1):50-6. PubMed ID: 24768600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
